Abstracts of papers

G. Tognoni; Charles Medawar; M. Romero; F. Venturini; R. Di Pasquale; M. Font; J. -P. Boissel; Alessandro Liberati; R. Rampazzo; G. Scroccaro; Valter Torri; R. Fossati; A. Liberati; S. Marsoni; J. Altimiras; R. Di Pasquale; C. Cattaruzzi; L. Aqostinis; M. Maggini; L. A. Garcia Rodriguez; R. Raschetti; G. Simon; M. G. Troncon; Andrew Herxheimer; G. Mignot; D. Bardelay; G. F. Nasi; M. Bonati; A. Messori; Wan Po A. Li; R. Rampaszo; M. van Hooreweghe; H. Robays; J. Rømsing; J. Møller-Sonnergaard; S. Hertel; M. Rasmussen; Sybil Todd; Sally Nuessle; I. Carlen; M. Tanner; C. Reinke; S. Marty; S. Saponaro; R. Luzzi; C. B. Claesson; C. Cornelius; M. Thorslund; B. Winblad; Hubert G. Leufkens; Eibert R. Heerdink; Albert Bakker; M. C. J. M. Sturkenboom; A. Middelbeek; L. T. W. de Jong van den Berg; PB van den Berg; BHCh Stricker; Silvio Garattini; G. Conti; G. Hazebroucq; A. Raza; D. Labbrozzi; A. Nicolucci; Behalf of the Gruppo Italiano per l'Apnlicazione della Dichiarazione di S.Vincent; Wiklund Ingela; Carlo Lucioni; M. S. Salek; A. R. Griffith; C. Spiller; D. K. Luscombe; A. J. Bayer

doi:10.1007/BF01876919

Pharmacy World and Science

October 1994, Volume 16, Supplement 5, pp 3–12 | Cite as

Abstracts of papers

Authors
Authors and affiliations

Tognoni G.
Charles Medawar
M. Romero
F. Venturini
R. Di Pasquale
M. Font
J. -P. Boissel
Alessandro Liberati
R. Rampazzo
G. Scroccaro
Valter Torri
R. Fossati
A. Liberati
S. Marsoni
J. Altimiras
R. Di Pasquale
C. Cattaruzzi
L. Aqostinis
M. Maggini
L. A. Garcia Rodriguez
R. Raschetti
G. Simon
M. G. Troncon
Andrew Herxheimer
Mignot G.
Bardelay D.
G. F. Nasi
M. Bonati
Messori A.
Li Wan Po A.
Rampaszo R.
M. van Hooreweghe
H. Robays
J. Rømsing
J. Møller-Sonnergaard
S. Hertel
M. Rasmussen
Sybil Todd
Sally Nuessle
I. Carlen
M. Tanner
C. Reinke
S. Marty
S. Saponaro
R. Luzzi
Claesson C. B.
Cornelius C.
Thorslund M.
Winblad B.
Hubert G. Leufkens
Eibert R. Heerdink
Albert Bakker
M. C. J. M. Sturkenboom
A. Middelbeek
L. T. W. de Jong van den Berg
PB van den Berg
BHCh Stricker
Silvio Garattini
G. Conti
G. Hazebroucq
Raza A.
D. Labbrozzi
A. Nicolucci
Behalf of the Gruppo Italiano per l'Apnlicazione della Dichiarazione di S.Vincent
Wiklund Ingela
Carlo Lucioni
M. S. Salek
A. R. Griffith
C. Spiller
D. K. Luscombe
A. J. Bayer

Article

50 Downloads

This is a preview of subscription content, to check access.

Preview

Unable to display preview. Download preview PDF.

References

Kramer M.S. Clinical epidemiology and biostatistics. Springer-Verlag. 1988, Springer-Verlag, New York, Berlin, Heilderberg.Google Scholar
Schlesselman J.J. Case Control Studies, design, conduct, analysis. Oxford University Press, 1982 New York.Google Scholar
Strom B.L. (edit). Pharmacoepidemiology Churchill Livingstone, 1989, New York.Google Scholar
Hartzema A.G. Porta M.S. Tilson H.H. (edts). Pharmacoepidemiology: an introduction. Second edit. Harvey Whitney Books Company, 1991, Cincinnati.Google Scholar

References

Garcia Rodriguez LA, Williams R, Derby LE, Dean AD, Jick H. Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med 1994; 154:311–316.PubMedGoogle Scholar
Garcia Rodriguez LA, Pérez Gutthann S, Walker AM, Lueck L. The role of non-steroidal anti-inflammatory drugs in acute liver injury. BMJ 1992; 305:865–868.PubMedGoogle Scholar

References

Surendrakumar D., Hospital admission and the start of benzodiazepine use. Brit. Med. J. 1992; 304: 881PubMedGoogle Scholar
Mathew A., Benzodiazepine Prescribing at Western Hospital. Aust. J. Hosp. Pharm. 1993; 23: 134–5Google Scholar
Huston P., Moderating Benzodiazepine Use in the Elderly Con. Fam. Phys. 1992; 38: 2459–67Google Scholar

Copyright information

Authors and Affiliations

Tognoni G.
- 1
Charles Medawar
- 2
M. Romero
- 3
- 10
F. Venturini
- 3
- 10
R. Di Pasquale
- 3
M. Font
- 4
J. -P. Boissel
- 5
Alessandro Liberati
- 6
R. Rampazzo
- 7
G. Scroccaro
- 7
Valter Torri
- 8
R. Fossati
- 8
A. Liberati
- 8
S. Marsoni
- 8
J. Altimiras
- 9
R. Di Pasquale
- 10
C. Cattaruzzi
- 11
L. Aqostinis
- 12
M. Maggini
- 13
L. A. Garcia Rodriguez
- 14
R. Raschetti
- 13
G. Simon
- 11
M. G. Troncon
- 11
Andrew Herxheimer
- 15
Mignot G.
Bardelay D.
G. F. Nasi
- 16
M. Bonati
- 17
Messori A.
Li Wan Po A.
Rampaszo R.
M. van Hooreweghe
- 18
H. Robays
- 18
J. Rømsing
- 19
J. Møller-Sonnergaard
- 19
S. Hertel
- 20
M. Rasmussen
- 19
Sybil Todd
Sally Nuessle
I. Carlen
- 22
M. Tanner
- 23
C. Reinke
- 24
S. Marty
- 22
S. Saponaro
- 25
R. Luzzi
- 25
Claesson C. B.
- 28
Cornelius C.
- 26
Thorslund M.
- 27
Winblad B.
- 26
Hubert G. Leufkens
- 29
Eibert R. Heerdink
- 29
Albert Bakker
- 29
M. C. J. M. Sturkenboom
- 30
- 31
A. Middelbeek
- 30
- 31
L. T. W. de Jong van den Berg
- 30
- 31
PB van den Berg
- 30
- 31
BHCh Stricker
- 30
- 31
Silvio Garattini
- 32
G. Conti
- 33
G. Hazebroucq
- 21
Raza A.
- 34
D. Labbrozzi
- 35
A. Nicolucci
- 35
Behalf of the Gruppo Italiano per l'Apnlicazione della Dichiarazione di S.Vincent
Wiklund Ingela
- 36
Carlo Lucioni
- 37
M. S. Salek
- 38
- 26
A. R. Griffith
- 38
C. Spiller
- 38
D. K. Luscombe
- 38
A. J. Bayer
- 38

1.Istituto di Ricerche Farmacologiche “Mario Negri”MilanoItaly
2.Social Audit LtdLondonUK
3.Centro Studi SIFOConsorzio Mario Negri SudS. Maria Imbaro (Chicti)Italy
4.Settore Farmaceutico USL 25VeronaItaly
5.Service de Pharmacologie CliniqueLyon Cedex 3France
6.Laboratorio di Epidemiologia ClinicaIstituto di Ricerche Farmacologiche “Mario Ncgri”MilanoItaly
7.Policlinico HospitalVeronaItaly
8.Laboratorio di Epidemiologia Clinica dei TumoriIstituto di Ricerche Farmacologiche “Mario Negri”Milano
9.Pharmacy ServiceBarcelonaSpain
10.Centro Studi SIFOConsorzio M.Negri SudS.Maria Imbaro (Chieti)Italy
11.Direzione Regionale SanitàTrieste
12.INSIEL S.p.A.Udine
13.Lab. Epidem. Biost. Ist. Superiore SanitàRomaItaly
14.CEIFE, IUCA, Universidad ComplutenseMadridSpain
15.UK Cochrane CentreNHS Rs&D ProgrammeOxfordUK
16.Farmacie Comunali Riunite (FCR)Reggio EmiliaItaly
17.Laboratory for Mother and Child HealthIstituto di Ricerche Farmacologiche ‘Mario Negri’MilanoItaly
18.Pharmacy ServicesUniversity HospitalGentBelgium
19.Department of PharmaceuticsThe Royal Danish School of PharmacyCopenhagenDenmark
20.The State University Hospital of CopenhagenCopenhagenDenmark
21.King Faisal Specialist Hospital & Research CentreRiyadhSaudi Arabia
22.Zentralinstitut der Walliser SpitälerSwitzerland
23.Schwerzerisches TropeninstitutBasclSwitzerland
24.Pharmazeutisches Institut der Universität BaselBaselSwitzerland
25.Pharmacy ServiceUniversity Hospital of BariBariItaly
26.Stockholm Gerontology Research Center & Department of Geriatric MedicineKarolinska InstituteStockholmSweden
27.Department of Social MedicineUniversity HospitalUppsalaSweden
28.School of Social SciencesStockholm UniversityStockholmSweden
29.Department of Pharmacoepidemiology and PharmacolhcrapyUtrecht UniversityTB UtrechtThe Netherlands
30.Department of Social Pharmacy and PharmacoepidemiologyAW GroningenThe Netherlands
31.Center for Monitoring of Adverse Reactions to DrugsRijswijkThe Netherlands
32.Istituto di Ricerche Farmacologiche “Mario Negri”MilanItaly
33.EMEA - Committee for Veterinary DrugsThe Netherlands
34.Clinical Research Group, Medical Affairs Dept.Zeneca PharmaceuticalsAlderley ParkEngland
35.Laboratorio di Farmacologia Clinica ed EpidemiologiaConsorzio Mario Negri SudS. Maria Imbaro (Chieti)Italia
36.Behavioural MedicineAstra HässleSweden
37.Institute of Health EconomicsMilano
38.Division of Clinical Pharmacy and § Department of Geriatric MedicineUniversity of WalesCardiffUK

Abstracts of papers

Preview

References

References

References

Copyright information

Authors and Affiliations

Personalised recommendations

Cite article